BridgeMD
Hip Infiltration in Hip Arthroplasty (HiHa) study – a randomized controlled trial
EU CTIS ID: 2023-509109-57-01
What this study is testing
The main objective is to determine if preoperative intra-articular infiltration (IAI) of the hip joint with Ropivacaine and Adrenaline reduces the number of patients needing postoperative escape pain medication after total hip arthroplasty, compared to a placebo AIA of the hip joint.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age > 18 years
- On the waiting list for primary THA via the ASI by one of participating orthopaedic surgeons
- ASA 1, ASA 2 or ASA 3
- Eligible to receive the full enhanced recovery pain- and anesthetic protocol
- Willing to participate
- Willing to provide written informed consent
You likely can't join if
- Decline to participate
- Participants will be excluded postoperatively if the duration of surgery exceeds 90 minutes
- Unable to effectively communicate in Dutch or English
- ASA 4
- Use of opioids preoperatively
- Use of NSAID’s for an indication other than the hip for which surgery is planned
See the full eligibility criteria
- Age > 18 years
- On the waiting list for primary THA via the ASI by one of participating orthopaedic surgeons
- ASA 1, ASA 2 or ASA 3
- Eligible to receive the full enhanced recovery pain- and anesthetic protocol
- Willing to participate
- Willing to provide written informed consent
- Decline to participate
- Participants will be excluded postoperatively if the duration of surgery exceeds 90 minutes
- Unable to effectively communicate in Dutch or English
- ASA 4
- Use of opioids preoperatively
- Use of NSAID’s for an indication other than the hip for which surgery is planned
- Allergy or contraindication for the contents (Ropivacaine or adrenaline) of the preoperative infiltration
- Allergy or contraindication for medication used in the standardized postoperative pain protocol
- Allergy or contraindication for medication used in the standardized anaesthetic protocol
- Allergy or contraindication for the standardized escape medication
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.